Radcliffe Capital Management L.P. acquired a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 119,539 shares of the company’s stock, valued at approximately $2,204,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Tuttle Capital Management LLC bought a new stake in shares of Translational Development Acquisition during the fourth quarter worth approximately $461,000. Wealthspring Capital LLC acquired a new position in Translational Development Acquisition in the 4th quarter valued at $1,095,000. Yakira Capital Management Inc. bought a new position in Translational Development Acquisition during the 4th quarter worth $1,106,000. Warberg Asset Management LLC acquired a new stake in shares of Translational Development Acquisition during the fourth quarter worth $1,373,000. Finally, Mizuho Securities USA LLC bought a new stake in shares of Translational Development Acquisition in the fourth quarter valued at about $2,305,000.
Translational Development Acquisition Stock Performance
NASDAQ:TDACU opened at $10.16 on Monday. Translational Development Acquisition Corp. has a 52 week low of $10.00 and a 52 week high of $10.30. The business’s 50-day simple moving average is $10.15.
Translational Development Acquisition Company Profile
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
Recommended Stories
- Five stocks we like better than Translational Development Acquisition
- What is a Secondary Public Offering? What Investors Need to Know
- Alcoa’s Solid Earnings Don’t Make Tariff Math Easier for AA Stock
- What Makes a Stock a Good Dividend Stock?
- Applied Digital: AI Data Center Hype or Real Value?
- How to Invest in Blue Chip Stocks
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.